[Antitoxoplasmotic treatment during pregnancy].
D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011739:Pyrimethamine / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D011739:Pyrimethamine
Tratamiento antitoxoplasmósico aplicado durante el embarazo.